Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-(6-bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium Bromide
2. Dicetel
3. Eldicet
4. Pinaverium
1. 53251-94-8
2. Dicetel
3. Pinaverium Bromide [inn]
4. Lat-1717
5. Pinaverium Bromide (inn)
6. Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, Bromide (1:1)
7. Pinaverii Bromidum
8. 4-(2-bromo-4,5-dimethoxybenzyl)-4-(2-(2-(6,6-dimethylbicyclo[3.1.1]heptan-2-yl)ethoxy)ethyl)morpholin-4-ium Bromide
9. Bromuro De Pinaverio
10. Bromure De Pinaverium
11. Lat 1717
12. Pinaverii Bromidum [inn-latin]
13. Bromure De Pinaverium [inn-french]
14. Bromuro De Pinaverio [inn-spanish]
15. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium;bromide
16. 4-(6-bromoveratryl)-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)morpholinium Bromide
17. Ncgc00181763-01
18. Einecs 258-450-0
19. 7scf54h12j
20. Unii-7scf54h12j
21. Pinaveriumbromide-d4
22. Dsstox_cid_28540
23. Dsstox_rid_82812
24. Dsstox_gsid_48614
25. Schembl25474
26. Morpholinium, 4-(2-bromo-4,5-dimethoxy)benzyl-4-(2-(2-(6,6-dimethyl-2-norpinyl)ethoxy)ethyl)-, Bromide
27. Chembl1909298
28. Dtxsid2048614
29. 4-[(2-bromo-4,5-dimethoxy-phenyl)methyl]-4-[2-[2-[(1s,5s)-6,6-dimethylnorpinan-2-yl]ethoxy]ethyl]morpholin-4-ium Bromide
30. Bcp21168
31. Tox21_112949
32. Mfcd01713435
33. Akos015918115
34. Gs-6842
35. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]-hept-2-yl)ethoxy]ethyl]morpholinium Bromide
36. Cas-53251-94-8
37. Hy-111613
38. Cs-0088569
39. Ft-0673906
40. P2753
41. D07094
42. Lat 1717; Lat-1717; Lat1717
43. A870784
44. Q27268790
45. 4-(2-bromo-4,5-dimethoxybenzyl)-4-{2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl}morpholin-4-ium Bromide
46. 4-[(2-bromo-4,5-dimethoxy-phenyl)methyl]-4-[2-[2-(6,6-dimethylnorpinan-2-yl)ethoxy]ethyl]-1-oxa-4-azoniacyclohexane Bromide
47. 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-(2-{6,6-dimethylbicyclo[3.1.1]heptan-2-yl}ethoxy)ethyl]morpholin-4-ium Bromide
48. Morpholinium,4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]-, Bromide
| Molecular Weight | 591.4 g/mol |
|---|---|
| Molecular Formula | C26H41Br2NO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 10 |
| Exact Mass | 591.13818 g/mol |
| Monoisotopic Mass | 589.14023 g/mol |
| Topological Polar Surface Area | 36.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 596 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
A Pinaverium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pinaverium Bromide, including repackagers and relabelers. The FDA regulates Pinaverium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pinaverium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pinaverium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pinaverium Bromide supplier is an individual or a company that provides Pinaverium Bromide active pharmaceutical ingredient (API) or Pinaverium Bromide finished formulations upon request. The Pinaverium Bromide suppliers may include Pinaverium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Pinaverium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pinaverium Bromide DMF (Drug Master File) is a document detailing the whole manufacturing process of Pinaverium Bromide active pharmaceutical ingredient (API) in detail. Different forms of Pinaverium Bromide DMFs exist exist since differing nations have different regulations, such as Pinaverium Bromide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pinaverium Bromide DMF submitted to regulatory agencies in the US is known as a USDMF. Pinaverium Bromide USDMF includes data on Pinaverium Bromide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pinaverium Bromide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pinaverium Bromide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pinaverium Bromide Drug Master File in Korea (Pinaverium Bromide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pinaverium Bromide. The MFDS reviews the Pinaverium Bromide KDMF as part of the drug registration process and uses the information provided in the Pinaverium Bromide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pinaverium Bromide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pinaverium Bromide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pinaverium Bromide suppliers with KDMF on PharmaCompass.
A Pinaverium Bromide written confirmation (Pinaverium Bromide WC) is an official document issued by a regulatory agency to a Pinaverium Bromide manufacturer, verifying that the manufacturing facility of a Pinaverium Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pinaverium Bromide APIs or Pinaverium Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Pinaverium Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Pinaverium Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pinaverium Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pinaverium Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pinaverium Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pinaverium Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pinaverium Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pinaverium Bromide suppliers with NDC on PharmaCompass.
Pinaverium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pinaverium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pinaverium Bromide GMP manufacturer or Pinaverium Bromide GMP API supplier for your needs.
A Pinaverium Bromide CoA (Certificate of Analysis) is a formal document that attests to Pinaverium Bromide's compliance with Pinaverium Bromide specifications and serves as a tool for batch-level quality control.
Pinaverium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Pinaverium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pinaverium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Pinaverium Bromide EP), Pinaverium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pinaverium Bromide USP).
LOOKING FOR A SUPPLIER?
